Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
McMurray JJV1, Solomon SD1, et al.; DAPA-HF Trial Committees and Investigators.
N Engl J Med. 2019 Sep 19.
http://doi.org/10.1056/NEJMoa1911303

Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK.
Bain SC, Bakhai A, Evans M, Green A, Menown I, Strain WD.
Diabet Med. 2019 Sep;36(9):1063-1071.
http://doi.org/10.1111/dme.14058

Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
RISE Consortium.
Diabetes Care. 2019 Sep;42(9):1742-1751.
http://doi.org/10.2337/dc19-0556

Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK.
Bain SC, Bakhai A, Evans M, Green A, Menown I, Strain WD.
Diabet Med. 2019 Sep;36(9):1063-1071.
http://doi.org/10.1111/dme.14058

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB, PIONEER 7 investigators.
Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539.
http://doi.org/10.1016/S2213-8587(19)30194-9

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Diabetes Care. 2019 Aug;42(8):1593-1603.
http://doi.org/10.2337/dci19-0028

Challenges in the management of people with diabetes and cancer.
Chowdhury TA, Jacob P.
Diabet Med. 2019 Jul;36(7):795-802.
http://doi.org/10.1111/dme.13919

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.
Miras AD, Pérez-Pevida B, Aldhwayan M, Kamocka A, McGlone ER, Al-Najim W, et al.
Lancet Diabetes Endocrinol. 2019 Jul;7(7):549-559.
http://doi.org/10.1016/S2213-8587(19)30157-3

Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up
Reaven, P,  Emanuele N, Wiitala, N et al  for the VADT Investigators
N Engl J Med 2019; 380:2215-2224
10.1056/NEJMoa1806802

Diabetes Diagnosis and Control: Missed Opportunities to Improve Health
The 2018 Kelly West Award LectureCatherine C. Cowie
Diabetes Care 2019 Jun; 42(6): 994-1004
http://doi.org/10.2337/dci18-0047